XML 66 R48.htm IDEA: XBRL DOCUMENT v3.22.4
Acquisitions - Narrative (Details) - USD ($)
$ in Millions
12 Months Ended
Jan. 03, 2023
Dec. 31, 2021
Dec. 31, 2020
Dec. 30, 2021
Dec. 08, 2021
Sep. 30, 2021
Feb. 25, 2021
Jan. 15, 2021
Business Acquisition [Line Items]                
Weighted-average amortization period   14 years            
The Binding Site Group | Subsequent Event                
Business Acquisition [Line Items]                
Weighted-average amortization period 17 years              
European Viral Vector Business                
Business Acquisition [Line Items]                
Goodwill recorded               $ 0
Mesa Biotech                
Business Acquisition [Line Items]                
Goodwill recorded             $ 0  
Lengnau biologics manufacturing facility                
Business Acquisition [Line Items]                
Goodwill recorded           $ 0    
PPD                
Business Acquisition [Line Items]                
Goodwill recorded         $ 0      
Net income attributable to Thermo Fisher Scientific Inc.   $ 7,369 $ 5,361          
Pro forma revenues   378            
Pro forma losses   (60)            
PPD | Non-recurring Pro Forma Adjustments, Transaction Costs                
Business Acquisition [Line Items]                
Net income attributable to Thermo Fisher Scientific Inc.   $ 312 $ (197)          
PeproTech                
Business Acquisition [Line Items]                
Goodwill recorded       $ 0        
Customer relationships                
Business Acquisition [Line Items]                
Weighted-average amortization period   17 years            
Product technology                
Business Acquisition [Line Items]                
Weighted-average amortization period   11 years            
Tradenames                
Business Acquisition [Line Items]                
Weighted-average amortization period   7 years            
Backlog                
Business Acquisition [Line Items]                
Weighted-average amortization period   3 years